Serum markers of rheumatoid arthritis in visceral leishmaniasis: Rheumatoid factor and anti-cyclic citrullinated peptide antibody

Journal of Autoimmunity

Volumn 28, Issue 1, 2007, Pages 55-58

  Atta, A M ^a   Carvalho, E M ^a   Jeronimo S M B ^b   Sousa Atta, M L B ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Autoimmunity; CCP Ab; RF IgA; RF IgM; Visceral leishmaniasis

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN PRODUCTION; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SERUM; TURBIDIMETRY; VISCERAL LEISHMANIASIS;

ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; LEISHMANIASIS, VISCERAL; PEPTIDES, CYCLIC; RHEUMATOID FACTOR;

EID: 33847018755     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2006.12.001     Document Type: Article

References (22)

1. Westwood O.M.R., Nelson P.N., and Hay F.C. Rheumatoid factors: what's new?. Rheumatology 45 (2006) 379-385
2. Dorner T., Egerer K., Feist E., and Burmester G.R. Rheumatoid factor revisited. Curr Opin Rheumatol 16 (2004) 246-253
3. Posnett D.N., and Edinger J. When do microbes stimulate rheumatoid factor?. J Exp Med 185 (1997) 1721-1723
4. Sutton B., Corper A., Bonagura V., and Taussig M. The structure and origin of rheumatoid factors. Immunol Today 21 (2000) 177-183
5. Watanabe K., Ohkubo Y., Funahashi Y., Nishimaki T., Moritoh T., Kasukawa R., et al. An investigation on rheumatoid factor of different immunoglobulin classes in hepatitis B virus carriers. Clin Rheumatol 10 (1991) 31-37
6. Carson D.A., Pojen P.C., and Kipps T.J. New roles for rheumatoid factor. J Clin Invest 87 (1991) 379-383
7. Roosnek E., and Lanzavecchia A. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J Exp Med 173 (1991) 487-489
8. Arnett F.C., Edworthy S., and Bloch D. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 21 (1988) 315-324
9. Pai S., Pai L., and Birkenfeldt R. Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis. Scand J Rheumatol 27 (1998) 252-256
10. Jonsson T., Arinbjarnarson S., Thorsteinsson J., Steinsson K., Geirsson A.J., Jonsson H., et al. Raised IgA rheumatoid factor (RF) but not IgM RF or IgG RF is associated with extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 24 (1995) 372-375
11. Wallbracht I., and Helmke K. Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Autoimmun Rev 4 (2005) 389-394
12. Peng S.L. Rheumatic manifestations of parasitic diseases. Semin Arthritis Rheum 31 (2002) 228-237
13. Galanakis E., Siamopoulou A., and Lapatsanis P.D. Leishmaniasis mimicking collagen disease. Lancet 350 (1997) 368-369
14. Carvalho E.M., Andrews B.S., Martinelli R., Dutra M., and Rocha H. Circulating immune complexes and rheumatoid factor in schistosomiasis and visceral leishmaniasis. Am J Trop Med Hyg 32 (1983) 61-68
15. Galvão-Castro B., Sa Ferreira J.A., Marzochi K.F., Marzochi M.C., Coutinho S.G., and Lambert P.H. Polyclonal B cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis. Clin Exp Immunol 56 (1984) 58-66
16. Argov S., Jaffe C.L., Krupp M., Slor H., and Shoenfeld Y. Autoantibody production by patients infected with Leishmania. Clin Exp Immunol 76 (1989) 190-197
17. Badaró R., Reed S.G., Barral A., Orge G., and Jones T.C. Evaluation of the micro enzyme-linked immunosorbent assay (ELISA) for antibodies in American visceral leishmaniasis: antigen selection for detection of infection-specific responses. Am J Trop Med Hyg 35 (1986) 72-78
18. Badaró R., Reed S.G., and Carvalho E.M. Immunofluorescent antibody test in American visceral leishmaniasis: sensitivity and specificity of different morphological forms of two Leishmania species. Am J Trop Med Hyg 32 (1983) 480-484
19. Frey A., Canzio J.D., and Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Method 221 (1998) 35-41
20. Newkirk M.M. Rheumatoid factors: host resistance or autoimmunity. Clin Immunol 104 (2002) 1-13
21. Miles S., Conrad S.M., Alves R.G., Jeronimo S.M.B., and Mosser D.M. A role for IgG complexes during infection with the intracellular pathogen Leishmania. J Exp Med 201 (2005) 747-754
22. Zendman A.J.W., van Venrooij W.J., and Pruijn G.J.M. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology 45 (2006) 20-25